ASPEN PHARMACARE HOLDINGS LIMITED - Retraction of Democratic Alliance allegations that Aspen engaged in anti-competitive conduct

Retraction of Democratic Alliance allegations that Aspen engaged in anti-competitive conduct

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Aspen Group”)



RETRACTION OF DEMOCRATIC ALLIANCE ALLEGATIONS THAT ASPEN ENGAGED IN ANTI-
COMPETITIVE CONDUCT

Shareholders are referred to the Aspen Holdings SENS Announcement of 24 April 2017 wherein it was
confirmed that the Democratic Alliance (“the DA”) had requested the South African Competition
Commission to investigate the alleged anti-competitive conduct of Aspen in South Africa.

Aspen had further confirmed in this announcement that pharmaceutical prices are approved by the
Department of Health in terms of the Single Exit Price regulatory framework which establishes a
universal fixed price for each pharmaceutical product and that Aspen had not increased pricing of its
products outside of this regulatory framework.

Aspen is pleased to note that the DA released a statement on 29 May 2017 wherein it confirms that:
“Following extensive high-level engagements between Aspen Pharmacare and the Health Portfolio of
the Democratic Alliance, necessitated by a previous press release, the DA is satisfied that there is no
evidence that Aspen is involved in the same practices that they are accused of having pursued in
Europe.”


Durban
30 May 2017



Sponsor:
Investec Bank Limited

Date: 30/05/2017 08:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.